Rising Cost of Cancer Pharmaceuticals: Cost Issues and Interventions to Control Costs
Authors:
- 12 November 2016
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 37 (1) , 85-93
Abstract
The rising cost of pharmaceuticals and, in particular, cancer drugs has made headline news in recent years. Several factors contribute to increasing costs and the burden this places on the health care system and patients. Some of these factors include costly cancer pharmaceutical research and development, longer clinical trials required to achieve drug approval, manufacturing costs for complex compounds, and the economic principles surrounding oncology drug pricing. Strategies to control costs have been proposed, and some have already been implemented to mitigate cancer drug costs such as the use of clinical treatment pathways and tools to facilitate cost discussions with patients. In this article, we briefly review some of the potential factors contributing to increasing cancer pharmaceutical costs and interventions to mitigate costs, and touch on the role of health care providers in addressing this important issue.Keywords
This publication has 22 references indexed in Scilit:
- Innovation in the pharmaceutical industry: New estimates of R&D costsJournal of Health Economics, 2016
- High Cancer Drug Prices in the United States: Reasons and Proposed SolutionsJournal of Oncology Practice, 2014
- Cancer Drugs in the United States: Justum Pretium—The Just PriceJournal of Clinical Oncology, 2013
- Market spiral pricing of cancer drugsCancer, 2013
- The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML expertsBlood, 2013
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011
- Improving Pharmaceutical Product Development and Manufacturing: Impact on Cost of Drug Development and Cost of Goods Sold of PharmaceuticalsJournal of Pharmaceutical Innovation, 2008
- Analysis of Manufacturing Costs in Pharmaceutical CompaniesJournal of Pharmaceutical Innovation, 2008
- Economics of New Oncology Drug DevelopmentJournal of Clinical Oncology, 2007
- Estimating The Cost Of New Drug Development: Is It Really $802 Million?Health Affairs, 2006